On Sep. 22, Harbin Medisan Pharmaceutical Co., Ltd. (stock: Hasanlian; stock code: 002900) was listed in SZSE and a grand listing ceremony was held. The party committee member of SZSE the vice-general manager Li Hui and the president and general manager of Harbin Medisan Pharmaceutical Co., Ltd., the vice president of Essence Securities Co., Ltd., the vice-president of Harbin Medisan Pharmaceutical Co., Ltd. Zhuge Guomin, the provincial and municipal government leaders, the institution shareholder representative , the listed intermediary’s representative, the partner clients and company’s executives attended the listing ceremony, indicating that the company will possess more abundant development resources and wider development platform. The president and general manager of Harbin Medisan Pharmaceutical Co., Ltd., Qin Jianfei made a speech, expressing the company’s successful listing benefited from the vigorous support of the governmental departments, enterprise partners and all walks of life. In the future, the company will follow the tenet that “Medisan, we are here for you”, abide by independent innovation and focus on wide market potential and innovative and generic drugs, follow the tenet of serving clinical demands designated to provide safe, effective products and superior services with leading technology, build a first-class pharmaceutical enterprise with core competitiveness to return shareholders and investors with better achievements and return society and make greater contributions to the economic development of Heilongjiang province.